Drug
SHR-1314 injection
SHR-1314 injection is a pharmaceutical drug with 3 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
2(67%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
1
33%
Ph phase_3
2
67%
Phase Distribution
0
Early Stage
1
Mid Stage
2
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
Phase 3Large-scale testing
2(66.7%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Completed(1)
Detailed Status
Recruiting1
Active, not recruiting1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
2
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 21 (33.3%)
Phase 32 (66.7%)
Trials by Status
recruiting133%
active_not_recruiting133%
completed133%
Recent Activity
2 active trials
Showing 3 of 3
active_not_recruitingphase_3
A Study of the Efficacy and Safety of SHR-1314 for Adult Active Psoriatic Arthritis
NCT06640257
recruitingphase_3
A Trial of SHR-1314 Injection in Adult Patients With Active Non-radiographic Axial Spondyloarthritis
NCT06860750
completedphase_2
Study of the Effectiveness and Safety of SHR-1314 for Psoriatic Arthritis
NCT05055934
Clinical Trials (3)
Showing 3 of 3 trials
NCT06640257Phase 3
A Study of the Efficacy and Safety of SHR-1314 for Adult Active Psoriatic Arthritis
NCT06860750Phase 3
A Trial of SHR-1314 Injection in Adult Patients With Active Non-radiographic Axial Spondyloarthritis
NCT05055934Phase 2
Study of the Effectiveness and Safety of SHR-1314 for Psoriatic Arthritis
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3